Eli Lilly CEO on drug prices: Patients are paying too much out-of-pocket costs

1 280
23.8%
Published on 20 Dec 2018, 15:08
Eli Lilly and Company CEO Dave Ricks on the drugs in the pharmaceutical company's pipeline, investing in R&D, the improving regulatory process for getting drugs to the market and efforts to get drug prices lower.
newstechmusic